Results 11 to 20 of about 2,196,436 (350)

Small molecule activation [PDF]

open access: yesDalton Transactions, 2016
The activation of small molecules has become an increasingly popular area of research over the last years, and there are many reasons to be captivated by this fascinating ...
Albrecht, Martin   +3 more
core   +5 more sources

Emerging Small Molecule Drugs [PDF]

open access: yes, 2014
Dyslipidaemia is a major risk factor for cardiovascular diseases. Pharmacological lowering of LDL-C levels using statins reduces cardiovascular risk. However, a substantial residual risk persists especially in patients with type 2 diabetes mellitus.
Colin, Sophie   +3 more
openaire   +2 more sources

De novo design of a homo-trimeric amantadine-binding protein. [PDF]

open access: yes, 2019
The computational design of a symmetric protein homo-oligomer that binds a symmetry-matched small molecule larger than a metal ion has not yet been achieved.
Adams   +36 more
core   +2 more sources

Synthesis, Characterization, and in vivo Evaluation of a Novel Potent Autotaxin-Inhibitor

open access: yesFrontiers in Pharmacology, 2022
The autotaxin-lysophosphatidic acid (ATX-LPA) signaling pathway plays a role in a variety of autoimmune diseases, such as rheumatoid arthritis or neurodegeneration.
Daniel Hunziker   +19 more
doaj   +1 more source

A photoactivatable small molecule probe for the in vivo capture of polyketide intermediates [PDF]

open access: yes, 2019
A photolabile carba(dethia) malonyl N‐acetylcysteamine derivative was devised and prepared for the trapping of biosynthetic polyketide intermediates following light activation.
Jenkins, Robert   +2 more
core   +1 more source

Efficient Industrial Synthesis of the MDM2 Antagonist Idasanutlin via a Cu(I)-catalyzed [3+2] Asymmetric Cycloaddition

open access: yesCHIMIA, 2018
A concise asymmetric synthesis has been developed to prepare idasanutlin, a small molecule MDM2 antagonist. Idasanutlin is currently being investigated as a potential treatment for various solid tumors and hematologic malignancies.
Dan Fishlock   +8 more
doaj   +1 more source

Application of Transition Metal Catalysis to Small Molecule Synthesis [PDF]

open access: yes, 2006
Over the past decade, transition metal catalysis has developed into a new field in organic synthesis, enabling numerous synthetic transformations that were previously not feasible.
Morrill, Christie
core   +1 more source

N-linoleyltyrosine protects neurons against Aβ1–40-induced cell toxicity via autophagy involving the CB2/AMPK/mTOR/ULK1 pathway

open access: yesBrain Research Bulletin, 2022
Beta-amyloid protein (Aβ) is one of the most important pathogenic factors of Alzheimer’s disease (AD). N-linoleyltyrosine (NITyr) was synthesized in our laboratory and exerted neuroprotective effects in APP/PS1 transgenic mice in previous reports.
Yi Zhou   +8 more
doaj   +1 more source

Small molecule induced reactivation of mutant p53 in cancer cells [PDF]

open access: yes, 2013
The p53 cancer mutant Y220C is an excellent paradigm for rescuing the function of conformationally unstable p53 mutants because it has a unique surface crevice that can be targeted by small-molecule stabilizers.
Adams   +58 more
core   +2 more sources

PEGylation of lipophilic SN38 prodrug with DSPE-mPEG2000 versus cremophor EL: comparative study for intravenous chemotherapy

open access: yesDrug Delivery, 2019
The lipophilic prodrug of hydrophobic drugs with well-designed molecular structures can form stable pure prodrug nanoparticles (NPs), but rapid NPs aggregation in plasma greatly restricted their direct use for intravenous chemotherapy.
Jun Zeng   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy